WuXi AppTec Reports Record First-Quarter In 2022
/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...
Source: prnewswire.com
Contract Testing Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Contract Testing Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Contract Testing Development Today - Breaking & Trending Today
Chimeric Therapeutics enters manufacturing partnership with Wuxi ATU to advance cancer pipeline
Chimeric Therapeutics Ltd (ASX:CHM) has entered into a strategic manufacturing partnership with WuXi Advanced Therapies, a global contract testing and...
Source: proactiveinvestors.com.au
Chimeric enters strategic manufacturing partnership with WuXi Advanced Therapies
MELBOURNE, Australia, April 11, 2022 (GLOBE NEWSWIRE) -- Chimeric Therapeutics (ASX:CHM, “Chimeric”) a clinical-stage cell therapy company and an Australian leader in cell therapy, is pleased to announce that it
Source: kulr8.com
WuXi AppTec Reports Strong Revenue Growth in 2021
/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...
Source: prnewswire.com
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing...
Source: prnewswire.com